Trials / Conditions / Pandemic Influenza Disease
Pandemic Influenza Disease
3 registered clinical trials studyying Pandemic Influenza Disease.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Immunogenicity, Tolerability and Safety of One or Two Doses of an Adjuvanted Swine-origin A H1N1 Influenza Vac NCT00992212 | Novartis Vaccines | Phase 2 |
| Completed | Safety, Tolerability and Immunogenicity of Two Doses of Adjuvanted Monovalent Influenza Vaccine Administered t NCT00841763 | Novartis | Phase 3 |
| Completed | Safety and Immunogenicity of Two Doses, Administered Three Weeks Apart, of Two(Surface Antigen Adjuvanted With NCT00311480 | Novartis | Phase 2 |